Karyopharm Therapeutics reported 0 in Dividend Yield for its fiscal quarter ending in March of 2025.





Dy Change Date
AbbVie 2.71 0.38 Jun/2026
Abbott 2.73 0.36 Jun/2026
Amgen 2.71 0.08 Jun/2026
AstraZeneca USD 1.75 0.57 Jun/2026
BioCryst Pharmaceuticals 0 0 Mar/2025
Bristol-Myers Squibb 4.36 0.23 Jun/2026
Eli Lilly 0.56 0.02 Jun/2026
Enanta Pharmaceuticals 0 0 Mar/2025
GlaxoSmithKline 0.86 0.03 Jun/2026
J&J 2.06 0.1 Jun/2026
Karyopharm Therapeutics 0 0 Mar/2025
Merck 2.62 0.14 Jun/2026
Nektar Therapeutics 0 0 Mar/2025
Novartis USD 3.1 0.23 Jun/2026
Novartis 3.1 0.21 Mar/2026
Pfizer 7.08 0.72 Jun/2026
Regeneron Pharmaceuticals 0.58 0.12 Jun/2026
Roche Holding 2.94 0.01 Jun/2026
Sangamo BioSciences 0 0 Mar/2025
Takeda 3.88 2.23 Jun/2026